Bandingkan Harga & Kinerja Magna Investama Mandiri Tbk. (MGNA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Magna Investama Mandiri Tbk. dan Organon Pharma Indonesia Tbk.: Magna Investama Mandiri Tbk. diperdagangkan di Rp142 (kapitalisasi pasar 463,91 M, volume 24 jam 244,26 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Magna Investama Mandiri Tbk. jauh lebih besar — sekitar 4,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MGNA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 463,91 M | 104,4 M |
Volume | 244,26 jt | — |
Lot | 2,44 jt | — |
Perputaran | 40,48 M | — |
Harga Rata-rata | 165,72 | — |
Nilai Transaksi | 40,48 M | — |
Harga Ekuilibrium Indikatif | 142 | — |
Volume Ekuilibrium Indikatif | 11,35 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Magna Investama Mandiri Tbk.
PT Magna Finance Tbk (the Company) formerly PT Arkasa Utama Leasing was established based on Notarial Deed No. 10 dated March 09, 1984 of James Jacinta Susanti, S.H.
Selengkapnya di halaman MGNA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
